Michelle Mierzwa

Michelle Mierzwa, MD

Assistant Professor

University Hospital
1500 E Medical Center Drive, UHB2C490
Ann Arbor, MI 48109-5010


Clinical Contacts


Administrative Contact

Kelley Coppola 734-936-7810


Dr. Mierzwa has 8 years of clinical experience in treatment of head and neck as well as gastrointestinal cancers.  Her clinical research interests have included novel chemoradiation regimens for head and neck cancers as well as pancreatic cancer.  Specifically, she is currently in collaboration with the Department of Otolaryngology as part of a clinical trial to identify radiographic and serum biomarkers for oropharynx cancer patients who may be eligible for de-escalation of chemoradiation.    

Areas of Interest

  • Head and neck cancer
  • Quality of life
  • De-escalation of treatment in oropharynx cancer
  • Metabolic imaging

Clinical Interests

  • Head and neck cancer
  • Gastrointestinal cancers

Honors & Awards

2011-2012  Association of Residents in Radiation Oncology Educator of the Year


  • MD, University of Cincinnati, 2003
  • MS, Biochemistry, Vanderbilt University, 1999
  • BS, Chemistry, Vanderbilt University, 1997
  • Board Certification: Radiation Oncology

Published Articles or Reviews

Selected from 8 publications

  • Mierzwa ML, Barrett WL, Redmond KP, et al. A randomized trial to assess the efficacy of intraoperative steroid use in decreasing acute urinary retention following transperineal radioactive I-125 implantation for prostate cancer. Cancer, 113(9):2605-9, 2008.
  • Mierzwa ML, Nyati M, Morgan M, et al. Recent advances in combined modality therapy. The Oncologist. 15(4):372-381; 2009-S105, 2010. PMC3227964.
  • Tuttle TR, Mierzwa ML, Wells SI, Fox SR, Ben-Jonathan N. The cyclic GMP/protein kinase G pathway as a therapeutic target in head and neck squamous cell carcinoma Cancer Lett. 370(2):279-85, 2016. PMC4711273

1500 E Medical Center Dr
Ann Arbor, MI 48109-5010